Three Japanese Growth Stocks With High Insider Ownership

In This Article:

Japan's stock markets have recently experienced sharp declines, with the Nikkei 225 Index falling 6.0% and the broader TOPIX Index down 5.6%, driven largely by pressure on technology stocks and a strengthening yen. Amid these turbulent market conditions, identifying growth companies with high insider ownership can provide valuable insights into potential investment opportunities. In this article, we will explore three Japanese growth stocks that not only exhibit strong growth characteristics but also boast significant insider ownership, which often signals confidence in the company's future prospects from those who know it best.

Top 10 Growth Companies With High Insider Ownership In Japan

Name

Insider Ownership

Earnings Growth

Hottolink (TSE:3680)

27%

59.7%

Micronics Japan (TSE:6871)

15.3%

39.8%

Kasumigaseki CapitalLtd (TSE:3498)

34.8%

43.3%

Medley (TSE:4480)

34%

28.7%

Kanamic NetworkLTD (TSE:3939)

25%

28.9%

SHIFT (TSE:3697)

35.4%

32.8%

Money Forward (TSE:3994)

21.4%

66.8%

ExaWizards (TSE:4259)

21.9%

91.1%

Astroscale Holdings (TSE:186A)

20.9%

90%

Soracom (TSE:147A)

16.5%

54.1%

Click here to see the full list of 100 stocks from our Fast Growing Japanese Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

DIP

Simply Wall St Growth Rating: ★★★★☆☆

Overview: DIP Corporation, a labor force solution company with a market cap of ¥163.09 billion, provides personnel recruiting services in Japan.

Operations: DIP Corporation's revenue segments include personnel recruiting services in Japan.

Insider Ownership: 39.1%

DIP Corporation, a growth company with high insider ownership in Japan, has seen earnings grow by 20% over the past year and is forecasted to continue growing at 13.7% per year, outpacing the JP market. The company's revenue is also expected to grow faster than the market at 11.4% annually. Recent strategic moves include a share repurchase program worth ¥5 billion aimed at enhancing shareholder value and improving capital efficiency.

TSE:2379 Ownership Breakdown as at Jul 2024
TSE:2379 Ownership Breakdown as at Jul 2024

PeptiDream

Simply Wall St Growth Rating: ★★★★★☆

Overview: PeptiDream Inc., a biopharmaceutical company with a market cap of ¥361.22 billion, focuses on the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.

Operations: The company generates revenue from the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.